- Home
- APVO vs KITT Comparison
APVO vs KITT Comparison
Compare APVO & KITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- KITT
- Stock Information
- Founded
- APVO 2016
- KITT 2014
- Country
- APVO United States
- KITT United States
- Employees
- APVO N/A
- KITT N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- KITT Industrial Machinery/Components
- Sector
- APVO Health Care
- KITT Industrials
- Exchange
- APVO Nasdaq
- KITT Nasdaq
- Market Cap
- APVO 6.5M
- KITT 5.8M
- IPO Year
- APVO N/A
- KITT N/A
- Fundamental
- Price
- APVO $4.46
- KITT $2.26
- Analyst Decision
- APVO Strong Buy
- KITT
- Analyst Count
- APVO 1
- KITT 0
- Target Price
- APVO $296.00
- KITT N/A
- AVG Volume (30 Days)
- APVO 90.6K
- KITT 17.0M
- Earning Date
- APVO 03-04-2025
- KITT 11-12-2024
- Dividend Yield
- APVO N/A
- KITT N/A
- EPS Growth
- APVO N/A
- KITT N/A
- EPS
- APVO N/A
- KITT N/A
- Revenue
- APVO N/A
- KITT $2,399,852.00
- Revenue This Year
- APVO N/A
- KITT $980.78
- Revenue Next Year
- APVO N/A
- KITT N/A
- P/E Ratio
- APVO N/A
- KITT N/A
- Revenue Growth
- APVO N/A
- KITT N/A
- 52 Week Low
- APVO $3.65
- KITT $0.82
- 52 Week High
- APVO $399.60
- KITT $17.14
- Technical
- Relative Strength Index (RSI)
- APVO 38.21
- KITT 51.00
- Support Level
- APVO $4.32
- KITT $1.91
- Resistance Level
- APVO $4.79
- KITT $3.44
- Average True Range (ATR)
- APVO 0.45
- KITT 1.02
- MACD
- APVO 0.15
- KITT -0.07
- Stochastic Oscillator
- APVO 19.53
- KITT 16.74
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About KITT Nauticus Robotics Inc.
Nauticus Robotics Inc develops autonomous robots for the ocean industries. The company's business model includes using robotic systems for service, selling vehicles and components, and licensing of related software to both the commercial and defense business sectors. Nauticus' services provide customers with the necessary data collection, analytics, and subsea manipulation capabilities to support and maintain assets while reducing their operational footprint, operating cost, and greenhouse gas emissions, to improve offshore health, safety, and environmental exposure.